Physician

Muad Maya, MD

According to 2025 Medicare claims, Muad Maya, MD (NPI: 1558322172) practices internal medicine in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is KIDNEY DOCTORS OF KENTUCKIANA PLLC (NPI: 1073961843; TIN: 812376397) and primary practice location at 40202-9998.

Maya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 502 traditional Medicare patients, billed 6,262 HCPCS/CPT codes, and received $371,635 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 978 prescription claims across 197 beneficiaries totaling $70,437 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 11 claims. Open Payments data shows 2 records totaling $152. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $212,450 and ending at $371,635. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $158,842 to $70,437. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,509 to $10,544.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	735	2,352	$212,450
2016	418	2,794	$241,609
2017	716	5,156	$379,750
2018	714	5,912	$428,304
2019	735	6,853	$501,116
2020	616	5,610	$410,609
2021	544	5,430	$417,954
2022	526	4,912	$354,732
2023	533	6,401	$471,456
2024	502	6,262	$371,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	174	1,336	$158,842
2016	93	373	$70,407
2017	123	831	$76,129
2018	156	893	$41,250
2019	176	898	$50,019
2020	172	737	$40,271
2021	168	786	$45,831
2022	162	787	$62,447
2023	217	1,072	$58,131
2024	197	978	$70,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	32	$1,433
2018	N/R	33	$1,308
2019	N/R	N/R	N/R
2020	N/R	22	$750
2021	N/R	36	$1,191
2022	N/R	71	$2,797
2023	N/R	11	$136
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	63	248	$144
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	335	412	$112
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	70	284	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	79	176	$58
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	350	3,193	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	17	540	$10,098
Lokelma	Sodium Zirconium Cyclosilicate	11	190	$5,617
Calcium Acetate	Calcium Acetate	59	2,686	$2,538
Potassium Chloride	Potassium Chloride	46	1,517	$2,468
Midodrine Hcl	Midodrine Hcl	21	631	$922

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$152	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Muad Maya, MD?

Tedicare shows public-source Medicare data for Muad Maya, MD (NPI 1558322172), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muad Maya, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Muad Maya, MD?

Muad Maya, MD is linked to KIDNEY DOCTORS OF KENTUCKIANA PLLC (billing NPI 1073961843) in the available physician profile data.

Does Muad Maya, MD have Open Payments data?

Muad Maya, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.